Orange Book product · Generic (ANDA)
DESONIDE
DESONIDE
At a glance
Mar 19, 2002
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 19, 2002
24 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
DESONIDE
Strength
0.05%
Dosage form
LOTION
Route
TOPICAL
TE code
AB
Application
ANDA 075860
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DESONIDE
- 2006DESONATEBrand (NDA)
NDA 021844 · LEO PHARMA AS
- 2006VERDESOBrand (NDA)
NDA 021978 · GENUS
- 1984DESOWENBrand (NDA)
NDA 019048 · GALDERMA LABS LP
- —DESONIDEBrand (NDA)
NDA 017010 · PADAGIS US
- —DESONIDEBrand (NDA)
NDA 017426 · PADAGIS US
- 2022DESONIDEGeneric (ANDA)
ANDA 214396 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 213632 · ALEMBIC
- 2020DESONIDEGeneric (ANDA)
ANDA 202470 · SENORES PHARMS
- 2019DESONIDEGeneric (ANDA)
ANDA 210198 · CADILA
- 2019DESONIDEGeneric (ANDA)
ANDA 212473 · ALEMBIC
- 2019DESONIDEGeneric (ANDA)
ANDA 212002 · PAI HOLDINGS PHARM
- 2019DESONIDEGeneric (ANDA)
ANDA 210998 · ENCUBE ETHICALS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
